FDA Approves Genentech’s Avastin (Bevacizumab) Plus Chemotherapy as a Treatment for Women With Advanced Ovarian Cancer Following Initial Surgery

World News: . []

Genentech a member of the Roche Group SIX RO ROG OTCQX RHHBY today announced that the US Food and Drug Administration FDA has approved Avastin bevacizumab in combination with chemotherapy carboplatin and paclita...

More news and information about Genentech

Published By:

Business Wire: 16:35 GMT Wednesday 13th June 2018

Published: .

Search for other references to "approves" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us